NKGen Biotech
NKGN----
全部股東
股東類型
- 公眾及其他49.64%
- 私人企業22.78%
- 個人與內幕人士17.72%
- 上市公司7.75%
- 機構投資者2.11%
主要股東
| 股東 | |||||
|---|---|---|---|---|---|
CFIC-2015 NV Family Investments, LLC | 16.66% | 2,175.29 萬 | 0.00% | +0 | |
Paul Y. SongCEO & Chairman | 16.10% | 2,102.08 萬 | 0.00% | +0 | |
NKGen Biotech Korea Co., Ltd. | 7.75% | 1,012.06 萬 | 0.00% | +0 | |
HekaBio K.K. | 6.13% | 800.00 萬 | 0.00% | +0 | |
Meteora Capital, LLC | 2.11% | 275.59 萬 | 0.00% | +0 | 30/06/2026 |
James GrafInterim Chief Financial Officer | 1.60% | 208.93 萬 | 0.00% | +0 | |
Yong Man KimChief Scientific Officer | 0.02% | 2.84 萬 | 0.00% | +0 | |
Kathleen ScottIndependent Director | 0.00% | 0.00 | 0.00% | +0 | |
Marco GottardisIndependent Director | 0.00% | 0.00 | 0.00% | +0 | |
Michael KlowdenIndependent Director | 0.00% | 0.00 | 0.00% | +0 |